Formulation and evaluation of sustained release microspheres of rosin containing aceclofenac
Keywords:
Aceclofenac, Rosin, Microspheres, Sustained releaseAbstract
Aceclofenac was microencapsulated using rosin by o/w emulsion solvent evaporationtechnique. The effect of three formulation variables including the drug:polymer ratio,emulsifier (polyvinyl alcohol) concentration and organic solvent (dichloromethane) volumewere examined. The prepared batches were characterized for microspheres particle sizedistribution, encapsulation efficiency and in vitro release behavior. The study reveals thatdrug:polymer ratio had a considerable effect on the entrapment efficiency, however particlesize distribution of microspheres was more dependent on the volume of dichloromethane andpolyvinyl alcohol concentration rather than on the drug: polymer ratio. Drug, polymerconcentrations were varied to obtain optimum release profile for sustaining the action of the drugDownloads
References
Jayakrishnan A, Latha MS. Biodegradable polymeric microspheres as drug carriers. In: Jain NK, Editor. Controlled and Novel drug delivery. New Delhi: CBS publishers. 1997. pp 236-255.
Vyas SP, Khar RK. Proteins and peptides delivery considerations. In: Vyas SP, Khar RK, Editor. Controlled drug delivery concepts and advances. 1st ed. New Delhi: CBS publisher and Distributor. 2002; pp 549.
Fu, X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behavior in vitro of huperzine A-PLGA microspheres. J Microencap 2005; 22(7): 705-714.
Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycocide) microcapsules: problems associated with preparative techniques and release properties. J Microencap 1990b; 7: 297–325.
Kawaguchi H. Functional polymer microspheres. Prog Polym Sci 2000; 25: 1171–1210.
Mueller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv Drug Deliv Review 2001; 47: 3–19.
Edlund U, Albertsson AC. Degradable polymer microspheres for controlled drug delivery. Adv Polymeric Science 2002; 157: 67–112.
Vasir JK, Tambwekar K, Garg GS. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003; 255: 13–32.
O’Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporatin technique. Adv Drug Deliv Reviews 1997; 28: 25-42.
Leelarasamee N, Howard SA, Malanga CJ, Ma JKH. A method for the preparation of poly(lactic acid) microcapsules of controlled particle size and drug loading. J Microencap 1988; 52: 147-157.
Bain DF, Munday DL, Smith A. Solvent influence on spray dried biodegradable microspheres. J Microencap 1999; 16: 453-474.
Jalil R, Nixon JR. Microencapsulation using poly(l-lactic acid) I: microcapsul properties affected by the preparative technique. J Microencap 1989; 6: 473 -484.
Huang YY, Chung TW, Tzeng TW. Drug release from PLA/PEG microparticulates. Int J Pharm 1997; 156: 9 -15.
Edlund U, Albertsson AC. Novel drug delivery microspheres from poly(1,5-dioxepan-2-one-co-l-lactide). J Poly sci: Part A: Poly che, 1999; 37: 1877–1884.
Oh JE, Nam YS, Lee KH, Park TG. Conjugation of drug poly(d,l-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. J Con Release 1999; 57: 269-280.
Pistel KF, Bittner B, Koll H, Winter G, Kissel T. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and start-branched block copolymers: influence of encapsulation technique and polymer composition on particle
characteristics. J Con Release 1999; 59: 309-325.
Bai XL, Yang YY, Chung TS, Ng S, Heller J. Effect of polymer compositions on the fabrication of poly(ortho-ester) microspheres for controlled release of protein. J Appl Poly Sci 2001; 80: 1630-1642.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).